Mobic and Psyllium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mobic (meloxicam) and Psyllium (blond psyllium). Common drug interactions include vomiting among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Mobic and Psyllium. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Mobic?

Mobic has active ingredients of meloxicam. It is often used in arthritis. eHealthMe is studying from 26,684 Mobic users. Check the latest studies of Mobic.

What is Psyllium?

Psyllium has active ingredients of blond psyllium. It is often used in constipation. eHealthMe is studying from 4,262 Psyllium users. Check the latest studies of Psyllium.



On Aug, 05, 2026

21 people who take Mobic and Psyllium together, and have interactions are studied.

Mobic and Psyllium drug interactions.

What are the common drug interactions of Mobic and Psyllium, by gender? *:

female:

  1. Vomiting
  2. Hyperhidrosis (abnormally increased sweating)
  3. Malaise (a feeling of general discomfort or uneasiness)
  4. Abdominal discomfort
  5. Agitation (state of anxiety or nervous excitement)
  6. Asthenia (weakness)
  7. Burning sensation
  8. Chills (felling of cold)
  9. Cystoid macular oedema (fluid accumulation after cataract surgery)
  10. Depression

male:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Intestinal perforation (complete penetration of the wall of the intestine)
  4. Renal tubular necrosis (death of kidney tubules)
  5. Sepsis (a severe blood infection that can lead to organ failure and death)

What are the common drug interactions of Mobic and Psyllium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Abdominal pain
  2. Abnormal dreams
  3. Allergy to plants
  4. Anxiety
  5. Attention deficit/hyperactivity disorder
  6. Blood pressure increased
  7. Cervical dysplasia (abnormal changes in the cells on the surface of the cervix)
  8. Cough
  9. Dehydration (dryness resulting from the removal of water)
  10. Depression

40-49:

  1. Restlessness (not able to rest)
  2. Urticaria (rash of round, red welts on the skin that itch intensely)
  3. Fatigue (feeling of tiredness)
  4. Abdominal distension
  5. Abdominal hernia
  6. Abdominal mass (localized enlargement or swelling in the human abdomen)
  7. Abdominal pain lower
  8. Abdominal wall abscess (abdominal wall infection)
  9. Abscess (pus)
  10. Activities of daily living impaired

50-59:

  1. Cystoid macular oedema (fluid accumulation after cataract surgery)
  2. Intraocular pressure increased
  3. Vision blurred
  4. Abdominal discomfort
  5. Burning sensation
  6. Chills (felling of cold)
  7. Fatigue (feeling of tiredness)
  8. Nausea (feeling of having an urge to vomit)
  9. Oedema peripheral (superficial swelling)
  10. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)

60+:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Arthropathy
  4. Back pain
  5. Bone disorder
  6. Burning sensation
  7. Chest pain
  8. Chronic fatigue syndrome (disorder that causes extreme fatigue)
  9. Crying
  10. Depressed mood

What are the existing conditions these people have? *

  1. Pain: 8 people, 38.10%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 28.57%
  3. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 23.81%
  4. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 23.81%
  5. High Blood Pressure: 3 people, 14.29%
  6. Neuralgia (pain in one or more nerves): 3 people, 14.29%
  7. Fibromyalgia (a long-term condition which causes pain all over the body): 3 people, 14.29%
  8. Spinal Osteoarthritis (joint cartilage loss in spine): 3 people, 14.29%
  9. Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 2 people, 9.52%
  10. Cardiac Disorder: 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Mobic and Psyllium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Mobic and Psyllium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Mobic:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Psyllium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mobic and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Psyllium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on meloxicam and blond psyllium (the active ingredients of Mobic and Psyllium, respectively), and Mobic and Psyllium (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: